Studies have shown that “hot tumors” recognize and attack tumors by abundant CD4+ and CD8+ tumor infiltrating lymphocytes, which are generally associated with better prognosis as well as improved response to ICB (Chen and Mellman, 2017). Here, CD4 is linked to neoplasm.